| Literature DB >> 33122904 |
Sanghwa Lee1, Jung-Man Namgoong2, Miyeon Jue1, Yujin Joung1, Chae-Min Ryu3,4, Dong-Myung Shin4, Myung-Soo Choo3, Jun Ki Kim1,5.
Abstract
BACKGROUND: This study investigated the diagnosis of renal diseases using a biochip capable of detecting nano-sized biomarkers. Raman measurements from a kidney injury model were taken, and the feasibility of early diagnosis was assessed.Entities:
Keywords: ZnO nanorods; nano-sized biomarker; principal component analysis; renal injury; surface-enhanced Raman spectroscopy; ureteral obstruction
Mesh:
Substances:
Year: 2020 PMID: 33122904 PMCID: PMC7589161 DOI: 10.2147/IJN.S272500
Source DB: PubMed Journal: Int J Nanomedicine ISSN: 1176-9114
Scheme 1Schematic illustration of the overall experimental process. (A) The ligations were made using splint wires with diameters of 0.3 and 0.1 mm for mild and severe ureteral stenosis models, respectively, with the splint wires then removed to allow partial flow. (B) Urine samples are taken from the kidney (①) and bladder (②) after ureteral ligation. (C) Fabrication of a surface-enhanced Raman chip using ZnO nanorods and the process for the Raman signal acquisition and subsequent statistical analysis.
Figure 1Histopathological evaluation of rat kidney tissue. Hematoxylin/eosin (H&E) staining illustrates the tubulointerstitial histological differences in the kidneys of the (C and D) MO and (E and F) SO experimental groups compared with (A and B) the sham-operated (control) group. Tubular cell injury, including mild and severe dilation of collection tubules, is marked with red arrows, while the presence of inflammatory cell infiltrates is shown in the magnified black boxes. The red area in the Sirius red stained images for the (G) sham and (H) SO groups indicates extracellular matrix accumulation in the tubular basement membrane.
Figure 2FE-SEM images of urine drops on the SERS substrate. (A) Magnified SEM image illustrating three points: (B) the dried droplet interface, (C) the diffused area (between the red arrows), and (D) the bare SERS area. The 100,000 × magnified images (B–D) correspond to the points in (A).
Figure 4Averaged Raman spectra from urine samples from the severe obstruction model (purple and green lines), the mild obstruction model (blue and red lines), and the control procedure (red line). The standard deviation is represented by the shaded areas around the solid lines. The black dots indicate the collagen assignment peaks.
Figure 3Principal component analysis (PCA) of (A and B) all obstruction and sham urine samples (C and D) bladder samples only, and (E and F) kidney samples only.